FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage
The FDA's 180-day exclusivity gives the first generic drug maker to challenge a patent a head start in the market. It lowers drug prices-but loopholes let companies delay launches, costing patients billions.
Read More